Technical Analysis for RSLS - ReShape Lifesciences, Inc.

Grade Last Price % Change Price Change
F 4.03 1.51% 0.06
RSLS closed up 1.51 percent on Monday, August 2, 2021, on 33 percent of normal volume.
Earnings due: Aug 5
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Flat
Historical RSLS trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
MACD Bullish Signal Line Cross Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 1.51%
Spinning Top Other 1.51%
Older End-of-Day Signals for RSLS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 1% about 10 hours ago
60 Minute Opening Range Breakdown about 11 hours ago
Up 5% about 13 hours ago
10 DMA Support about 14 hours ago
Rose Above 10 DMA about 14 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


ReShape Lifesciences, Inc. Description

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.


Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Obesity Diabetes Mellitus Metabolic Diseases Neuromodulation Digestive System Surgery Laparoscopy Adjustable Gastric Band Bariatrics System

Is RSLS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 14.0
52 Week Low 1.14
Average Volume 4,038,834
200-Day Moving Average 0.00
50-Day Moving Average 5.13
20-Day Moving Average 4.22
10-Day Moving Average 4.05
Average True Range 0.59
ADX 18.14
+DI 29.49
-DI 19.25
Chandelier Exit (Long, 3 ATRs) 4.45
Chandelier Exit (Short, 3 ATRs) 5.38
Upper Bollinger Bands 4.85
Lower Bollinger Band 3.58
Percent B (%b) 0.35
BandWidth 30.26
MACD Line -0.35
MACD Signal Line -0.36
MACD Histogram 0.0114
Fundamentals Value
Market Cap 31.32 Million
Num Shares 7.77 Million
EPS -13.27
Price-to-Earnings (P/E) Ratio -0.30
Price-to-Sales 3.17
Price-to-Book 1.25
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.45
Resistance 3 (R3) 4.45 4.32 4.38
Resistance 2 (R2) 4.32 4.21 4.32 4.36
Resistance 1 (R1) 4.17 4.14 4.11 4.17 4.33
Pivot Point 4.04 4.04 4.00 4.04 4.04
Support 1 (S1) 3.89 3.93 3.83 3.89 3.73
Support 2 (S2) 3.76 3.86 3.76 3.70
Support 3 (S3) 3.61 3.76 3.68
Support 4 (S4) 3.61